0	10	Expression	expression	NN
11	13	of	of	IN
14	19	v-src	v-src	NN
20	22	in	in	IN
23	24	T	t	NN
25	30	cells	cell	NNS
31	41	correlates	correlate	VBZ
42	46	with	with	IN
47	54	nuclear	nuclear	JJ
55	65	expression	expression	NN
66	68	of	of	IN
69	77	NF-kappa	NF-kappa	NNP
78	80	B.	B.	NNP
82	90	NF-kappa	NF-kappa	NNP
91	92	B	B	NNP
93	95	is	be	VBZ
96	97	a	a	DT
98	105	rapidly	rapidly	RB
106	115	inducible	inducible	JJ
116	131	transcriptional	transcriptional	JJ
132	141	activator	activator	NN
142	146	that	that	WDT
147	155	responds	respond	VBZ
156	158	to	to	TO
159	160	a	a	DT
161	168	variety	variety	NN
169	171	of	of	IN
172	179	signals	signal	NNS
180	183	and	and	CC
184	194	influences	influence	VBZ
195	198	the	the	DT
199	209	expression	expression	NN
210	212	of	of	IN
213	217	many	many	JJ
218	223	genes	gene	NNS
224	232	involved	involve	VBN
233	235	in	in	IN
236	239	the	the	DT
240	246	immune	immune	JJ
247	255	response	response	NN
255	256	.	.	.

257	264	Protein	protein	NN
265	273	tyrosine	tyrosine	NN
274	281	kinases	kinase	NNS
282	290	transmit	transmit	VBP
291	298	signals	signal	NNS
299	303	from	from	IN
304	312	cytokine	cytokine	NN
313	316	and	and	CC
317	323	immune	immune	JJ
324	333	receptors	receptor	NNS
333	334	.	.	.

335	339	Very	very	RB
340	346	little	little	JJ
347	358	information	information	NN
359	365	exists	exist	VBZ
366	373	linking	link	VBG
374	379	these	these	DT
380	383	two	two	CD
384	393	important	important	JJ
394	401	classes	class	NNS
402	404	of	of	IN
405	414	signaling	signal	VBG
415	424	molecules	molecule	NNS
424	425	.	.	.

426	428	We	we	PRP
429	432	now	now	RB
433	444	demonstrate	demonstrate	VBP
445	449	that	that	IN
450	455	v-src	v-src	NN
456	466	expression	expression	NN
467	477	correlates	correlate	VBZ
478	482	with	with	IN
483	490	nuclear	nuclear	JJ
491	501	expression	expression	NN
502	504	of	of	IN
505	506	a	a	DT
507	512	kappa	kappa	NN
513	514	B	B	NNP
515	522	binding	binding	NN
523	530	complex	complex	NN
531	538	similar	similar	JJ
539	541	to	to	TO
542	546	that	that	DT
547	554	induced	induce	VBN
555	557	by	by	IN
558	565	phorbol	phorbol	NN
566	571	ester	ester	NN
572	575	and	and	CC
576	585	ionomycin	ionomycin	NN
585	586	,	,	,
587	589	as	as	IN
590	598	detected	detect	VBN
599	601	by	by	IN
602	617	electrophoretic	electrophoretic	JJ
618	626	mobility	mobility	NN
627	632	shift	shift	NN
633	638	assay	assay	NN
639	644	using	use	VBG
645	646	a	a	DT
647	654	variety	variety	NN
655	657	of	of	IN
658	663	kappa	kappa	NN
664	665	B	B	NNP
666	671	sites	site	NNS
671	672	.	.	.

673	677	This	this	DT
678	685	complex	complex	NN
686	689	was	be	VBD
690	697	blocked	block	VBN
698	700	by	by	IN
701	704	the	the	DT
705	713	tyrosine	tyrosine	NN
714	720	kinase	kinase	NNP
721	730	inhibitor	inhibitor	NN
730	731	,	,	,
732	742	herbimycin	herbimycin	NN
743	744	A	a	NN
744	745	.	.	.

746	749	The	the	DT
750	763	v-src-induced	v-src-induced	JJ
764	771	complex	complex	NN
772	781	comprised	comprise	VBD
782	785	the	the	DT
786	789	p50	p50	NN
790	793	and	and	CC
794	797	p65	p65	NN
798	808	components	component	NNS
809	811	of	of	IN
812	820	NF-kappa	NF-kappa	NNP
821	822	B	B	NNP
822	823	,	,	,
824	826	as	as	IN
827	837	determined	determine	VBN
838	840	by	by	IN
841	851	supershift	supershift	NN
852	855	and	and	CC
856	866	immunoblot	immunoblot	NN
867	875	analysis	analysis	NN
875	876	.	.	.

877	879	As	as	IN
880	881	a	a	DT
882	892	functional	functional	JJ
893	902	correlate	correlate	NN
903	905	of	of	IN
906	910	this	this	DT
911	918	finding	finding	NN
918	919	,	,	,
920	929	transient	transient	JJ
930	945	co-transfection	co-transfection	NN
946	948	of	of	IN
949	954	HIV-1	HIV-1	NNP
955	958	LTR	LTR	NNP
959	967	reporter	reporter	NN
968	978	constructs	construct	NNS
979	981	in	in	IN
982	983	a	a	DT
984	993	different	different	JJ
994	995	T	t	NN
996	1000	cell	cell	NN
1001	1005	line	line	NN
1006	1018	demonstrated	demonstrate	VBD
1019	1023	that	that	IN
1024	1029	v-src	v-src	NN
1030	1039	activated	activate	VBD
1040	1044	this	this	DT
1045	1053	promoter	promoter	NN
1054	1056	in	in	IN
1057	1058	a	a	DT
1059	1064	kappa	kappa	NN
1065	1076	B-dependent	b-dependent	JJ
1077	1083	manner	manner	NN
1083	1084	.	.	.

1085	1087	We	we	PRP
1088	1093	found	find	VBD
1094	1098	that	that	IN
1099	1114	transactivation	transactivation	NN
1115	1117	of	of	IN
1118	1121	the	the	DT
1122	1127	HIV-1	HIV-1	NNP
1128	1131	LTR	LTR	NNP
1132	1134	by	by	IN
1135	1140	v-src	v-src	NN
1141	1144	was	be	VBD
1145	1149	more	more	RBR
1150	1159	sensitive	sensitive	JJ
1160	1162	to	to	TO
1163	1172	mutations	mutation	NNS
1173	1175	of	of	IN
1176	1179	the	the	DT
1180	1188	proximal	proximal	JJ
1188	1189	,	,	,
1190	1196	rather	rather	RB
1197	1201	than	than	IN
1202	1205	the	the	DT
1206	1212	distal	distal	JJ
1212	1213	,	,	,
1214	1219	kappa	kappa	NN
1220	1221	B	B	NNP
1222	1229	element	element	NN
1229	1230	.	.	.

1231	1234	The	the	DT
1235	1247	implications	implication	NNS
1248	1251	for	for	IN
1252	1253	T	t	NN
1254	1258	cell	cell	NN
1259	1267	receptor	receptor	NN
1268	1277	signaling	signaling	NN
1278	1281	and	and	CC
1282	1287	HIV-1	HIV-1	NNP
1288	1292	gene	gene	NN
1293	1303	expression	expression	NN
1304	1307	are	be	VBP
1308	1318	considered	consider	VBN
1318	1319	.	.	.